Cohen Cheryl
SEC Form 4 insider trading activity
Cohen Cheryl has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Oct 6, 2026.
On the most recent filing, Cohen Cheryl is listed as Director at ImmunityBio, Inc. Inside the rolling window, Cohen Cheryl reported no open-market purchases and 2 open-market sales totaling $2.1M in IBRX. The largest disclosed transaction in the window is a sale of 131,210 IBRX shares on Jul 2, 2026, worth $1.2M.
Companies traded
Other insiders at IBRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cohen Cheryl made?
Cohen Cheryl has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Cohen Cheryl trade?
Cohen Cheryl has filed SEC Form 4 disclosures for 1 company, including IBRX.
When was Cohen Cheryl's most recent SEC Form 4 filing?
Cohen Cheryl's most recent SEC Form 4 filing on Tracefour is dated Oct 6, 2026.
What is Cohen Cheryl's total buy and sell value in the current window?
Inside the rolling retention window, Cohen Cheryl bought $0 and sold $2.1M based on SEC Form 4 filings.
What was Cohen Cheryl's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 131,210 IBRX shares on 2026-07-02, worth $1.2M, per SEC Form 4 filings.